![]() |
Volumn 21, Issue 2, 2016, Pages 204-207
|
An analysis of FDA-approved drugs: Natural products and their derivatives
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATROPINE;
BACITRACIN;
BETAINE;
CAMPTOTHECIN;
CAPSAICIN;
CHLORTETRACYCLINE;
CODEINE;
COLCHICINE;
COMPACTIN;
CROFELEMER;
DAUNORUBICIN;
DOPAMINE;
EPHEDRINE;
FOLIC ACID;
HIRUDIN;
HYDROXYPROPYLCELLULOSE;
KHELLIN;
MEVINOLIN;
MITHRAMYCIN;
MORPHINE;
NATURAL PRODUCT;
NORDIHYDROGUAIARETIC ACID;
NOVOBIOCIN;
OXYTETRACYCLINE;
PHYTOMENADIONE;
SALICYLIC ACID;
SPINOSAD;
TETRACYCLINE;
THEBAINE;
UNINDEXED DRUG;
BIOLOGICAL PRODUCT;
CEPHALOSPORIUM;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG SAFETY;
DRUG SYNTHESIS;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MICROORGANISM;
NONHUMAN;
PENICILLIUM;
PLANT PRODUCT;
REVIEW;
STREPTOMYCES;
WILLOW;
ANIMAL;
BACTERIUM;
FUNGUS;
PLANT;
UNITED STATES;
ANIMALS;
BACTERIA;
BIOLOGICAL PRODUCTS;
DRUG APPROVAL;
FUNGI;
HUMANS;
PLANTS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84922106952
PISSN: 13596446
EISSN: 18785832
Source Type: Journal
DOI: 10.1016/j.drudis.2015.01.009 Document Type: Short Survey |
Times cited : (640)
|
References (16)
|